(Press-News.org) Chicago, Illinois (Embargoed until 9:30 am CDT, Monday, June 26, 2023)—Jean-Luc C. Urbain, MD, PhD, FASNC, professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo in New York, has been elected vice president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2023 Annual Meeting, held June 24-27.
“With the advent of new precision oncology nuclear therapies and the explosion of the field of theranostics, there has never been a more exciting time to practice nuclear medicine,” stated Urbain. “Nevertheless, the universal clinical implementation of new diagnostic and therapeutic radiopharmaceuticals faces significant challenges, particularly in the United States, where the approval of radiopharmaceuticals is usually more complex than in other countries. As SNMMI vice president-elect, I will focus on bringing these advances to the clinic, where they can benefit patients.”
As vice president-elect, Urbain will focus on implementing the society’s new strategic plan to address the current and universal challenges facing the global nuclear medicine community. Outreach to underrepresented professionals and communities in the United States will be a top priority. Urbain will also work with emerging countries to facilitate their participation in SNMMI activities and to expand their access to leadership positions. He will strive to promote the SNMMI brand across the globe to increase its visibility, membership and financial support.
A native of Belgium, Urbain earned his medical degree at the University of Louvain, Belgium, and then pursued residency training in internal medicine and nuclear medicine at the University Hospital of the University of Louvain in Brussels, Belgium. He subsequently obtained a Ph.D. in genetics and molecular biology at Temple University in Philadelphia.
Over his 35-year career, Urbain has held academic appointments at Catholic University of Louvain, Temple University, University of Western Ontario in London, Ontario, and most recently as Nuclear Radiology Fellowship Program Director at Wake Forest University in Winston-Salem, North Carolina. His hospital appointments include positions at Catholic University of Louvain; CHGH University Affiliated Hospital in Hornu, Belgium; Temple University Hospital; Fox Chase Cancer Center in Philadelphia, Pennsylvania; the Cleveland Clinic Foundation; St. Joseph’s Health Care, London Health Sciences Centre & University of Western Ontario; the VA Medical Center-Milton Hershey Penn State Medical College in Lebanon, Pennsylvania; Wake Forest Baptist Medical Center; and Brantford General, Pembroke Regional, and Stratford General Hospitals in Stratford, Ontario, where he currently is a staff physician in addition to his post at the Roswell Cancer Center.
Within SNMMI Urbain has served in multiple roles. He was a member of the Nominating Committee and on the Radiopharmaceutical Extravasation Task Force and served as chair of the Global Initiative Committee. Urbain is currently a member of the Therapy Strategic Plan Task Force, Quality and Patient Safety Committee, Center of Excellence Task Force and Therapy Center of Excellence Task Force. He is a member of the Eastern Great Lakes Chapter of SNMMI and served as president of the chapter from 2010-2011.
Additionally, Urbain is currently co-commissioner of the Lancet Oncology Commission Report on Theranostics and an International Atomic Energy Agency consultant. In the past, he served as president of the World Federation of Nuclear Medicine & Biology, vice president of the Canadian Neuro Endocrine Tumors Society, co-chair of the Waiting Time Alliance, president of the Canadian Society of Nuclear Medicine, and secretary of the Belgium Society of Nuclear Medicine.
Urbain is a member of the American Roentgen Ray Society, Radiological Society of North America, American Society of Clinical Oncology, American Society of Nuclear Cardiology and European Association of Nuclear Medicine. He received the Homi Jehangir Bhabba Award Honorary Degree in 2007 and the GE Radiant Fund from the Canadian Association of Nuclear Medicine in 2006. Urbain has published 75 journal articles and 15 book chapters and has given more than 500 invited speaker presentations.
Other SNMMI officers elected for 2023-24 are Helen Nadel, MD, FRCPC, Stanford, California, as president and Cathy Sue Cutler, PhD, FSNMMI, Upton, New York, as president-elect. SNMMI Technologist Section officers for 2023-24 are Dmitry Beyder, CNMT, MPA, St. Louis, Missouri, as president and Julie Dawn Bolin, MS, CNMT, Phoenix, Arizona, as president-elect.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
END
Chicago, Illinois (Embargoed until 9:30 am, CDT, Monday, June 26, 2023)—Umar Mahmood, MD, PhD, chief of Nuclear Medicine and Molecular Imaging, director of the Center for Precision Imaging, and associate chair for imaging sciences in the Department of Radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School in Boston, Massachusetts, has been named as the first recipient of the new Minoshima-Pappas Transformational Leadership Award. Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting.
The Minoshima-Pappas Transformational Leadership Award was ...
Chicago, Illinois (Embargoed until 9:30 am, CDT, Monday, June 26, 2023)—Peter J. H. Scott, PhD, associate professor of radiology and pharmacology, division director of nuclear medicine, and director of the PET Center at the University of Michigan in Ann Arbor, Michigan, has been named as the 2023 recipient of the Sam Gambhir Trailblazer Award. Scott was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting.
Scott's nuclear medicine and molecular imaging research spans ...
Cambridge scientists have set out principles for how computational science – which powers discoveries from unveiling the mysteries of the universe to developing treatments to fight cancer to improving our understanding of the human genome, but can have a substantial carbon footprint – can be made more environmentally sustainable.
Writing in Nature Computational Science, researchers from the Department of Public Health and Primary Care at the University of Cambridge argue that the scientific community needs to act now if it is to ...
New research led by the University of East Anglia (UEA) reduces uncertainty in future climate change linked to the stratosphere, with important implications for life on Earth.
Man-made climate change is one of the greatest challenges facing us today, but uncertainty in the exact magnitude of global change hampers effective policy responses.
A significant source of uncertainty relates to future changes to water vapour in the stratosphere, an extremely dry region of the atmosphere 15–50 km above the Earth’s surface.
Future increases in water vapour here risk amplifying climate change and slowing down the recovery ...
The opioid crisis continues to pose a grave public health concern, with synthetic opioids such as fentanyl posing a major risk for development of addiction and death due to overdose. In a ground-breaking development, a recent study by the research group led by Prof. Ami Citri at the Hebrew University of Jerusalem's Edmond and Lily Safra Center for Brain Sciences has unveiled crucial insights into the brain's potential ability to regulate the urge to consume fentanyl. This discovery offers a glimmer of hope in the ongoing battle against ...
About The Study: Racial disparities in food insecurity were found among low-income households that do not participate in Supplemental Nutrition Assistance Program (SNAP) but not among those that do, suggesting that access to SNAP should be improved. These results also highlight the need to examine the structural and systemic racism in food systems and in access to food assistance that may contribute to disparities.
Authors: Laura J. Samuel, Ph.D., R.N., of the Johns Hopkins School of Nursing in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.20196)
Editor’s ...
Pioneering analysis of deep-sea corals has overturned the idea that ocean currents contributed to increasing global levels of carbon dioxide in the air over the past 11,000 years.
The study, led by the University of Bristol in the UK and Nanjing University in China, examined historic deep-sea corals to shed intriguing new light on the history of ocean chemistry.
Understanding what has led to the pre-industrial rise in carbon dioxide (CO2) levels during the Holocene period, which dates back some 11,700 years to the present day, is a source of scientific debate. One theory suggests the increase in physical ...
By Benjamin Boettner
(Boston) — The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of the body, and reinfused back into the same patient, especially against blood cancers is well under way. But improving the ability to create patient-specific T cell populations with specific traits and functions could broaden clinicians’ repertoire of T cell therapies.
One way to approach this goal is to better understand how T cells’ traits and functions, including their cytotoxic effects on ...
HOUSTON ― Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.
The study, published today in Nature Cancer, demonstrates that the loss of a cluster of interferon receptor (IFNR) genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability. This genomic feature may be used to help clinicians predict a tumor’s potential to become metastatic and treatment resistant.
Researchers led by Luigi Perelli, ...
Scientists at the Sainsbury Laboratory Cambridge University (SLCU) have discovered a new molecular signalling pathway, triggered when leaves are exposed to low humidity, that ensures plant roots keep growing towards water.
In dry soil conditions, plants take action to try and conserve water by producing the drought stress hormone abscisic acid (ABA). For decades plant scientists thought that in response to dry soil, ABA was made in the roots and then transported to the leaves. In this root-to-shoot signalling pathway, ABA closes microscopic leaf pores, called stomata, to prevent water loss from leaves. In recent years, scientists ...
